Is deep learning having any impact on ADME/Tox?
What is it about?
This article is a commentary that followed an AI conference panel last year. Basically everyone chimes in other issues facing ADME/Tox modeling and what if any impact deep learning has had or could have in future on this topic.
Why is it important?
The panel consisted of scientists from Big Pharma and small biotech and presented very different opinions on the subject matter. We were able to go much deeper than we could at the conference.
The following have contributed to this page: Dr Sean Ekins